SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016471
Filing Date
2022-08-10
Accepted
2022-08-10 16:12:51
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q itos-20220630.htm   iXBRL 10-Q 2825825
2 EX-31.1 itos-ex31_1.htm EX-31.1 20415
3 EX-31.2 itos-ex31_2.htm EX-31.2 20419
4 EX-32.1 itos-ex32_1.htm EX-32.1 21675
  Complete submission text file 0000950170-22-016471.txt   9263518

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itos-20220630.xsd EX-101.SCH 57984
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itos-20220630_pre.xml EX-101.PRE 336499
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itos-20220630_lab.xml EX-101.LAB 443876
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itos-20220630_cal.xml EX-101.CAL 44984
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itos-20220630_def.xml EX-101.DEF 206514
61 EXTRACTED XBRL INSTANCE DOCUMENT itos-20220630_htm.xml XML 1706787
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39401 | Film No.: 221151957
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences